SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria PJ Feldblum, A Adeiga, R Bakare, S Wevill, A Lendvay, F Obadaki, ... PloS one 3 (1), e1474, 2008 | 329 | 2008 |
Towards the development of a longer-acting injectable contraceptive: past research and current trends V Halpern, RM Stalter, DH Owen, LJ Dorflinger, A Lendvay, ... Contraception 92 (1), 3-9, 2015 | 48 | 2015 |
Effectiveness, safety and acceptability of Sino-implant (II) during the first year of use: results from Kenya and Pakistan A Lendvay, R Otieno-Masaba, SK Azmat, A Wheeless, W Hameed, ... Contraception 89 (3), 197-203, 2014 | 30 | 2014 |
Preferences for a potential longer-acting injectable contraceptive: perspectives from women, providers, and policy makers in Kenya and Rwanda EE Tolley, K McKenna, C Mackenzie, F Ngabo, E Munyambanza, J Arcara, ... Global Health: Science and Practice 2 (2), 182-194, 2014 | 28 | 2014 |
Nevirapine-based antiretroviral therapy does not reduce oral contraceptive effectiveness K Nanda, S Delany-Moretlwe, K Dubé, A Lendvay, C Kwok, L Molife, ... Aids 27, S17-S25, 2013 | 20 | 2013 |
Continuous compared with cyclic use of oral contraceptive pills in the Dominican Republic: a randomized controlled trial K Nanda, A Lendvay, C Kwok, E Tolley, K Dubé, V Brache Obstetrics & Gynecology 123 (5), 1012-1022, 2014 | 16 | 2014 |
Performance of Sino-implant (II) in routine service delivery in Madagascar PJ Feldblum, O Hanitriniaina, A Lendvay, K Hopkins, A Wheeless, ... Contraception 88 (1), 103-108, 2013 | 13 | 2013 |
A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel DJ Taylor, A Lendvay, V Halpern, LG Bahamondes, PM Fine, SY Ginde, ... Contraception 89 (3), 215-221, 2014 | 11 | 2014 |
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-Provera V Halpern, V Brache, D Taylor, A Lendvay, L Cochón, JT Jensen, ... Fertility and sterility 115 (4), 1035-1043, 2021 | 10 | 2021 |
Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trial V Halpern, R Fuchs, V Brache, L Bahamondes, MJ Miranda, A Lendvay, ... Contraception: X 3, 100070, 2021 | 6 | 2021 |
Rationale, design, and cohort enrolment of a prospective observational study of the clinical performance of the new contraceptive implant (Femplant) in Pakistan SK Azmat, W Hameed, A Lendvay, BT Shaikh, G Mustafa, MA Siddiqui, ... International Journal of Women's Health, 573-583, 2014 | 4 | 2014 |
Exploration of a new procedure for sterilization by intrauterine instillation of a methylcellulose gel EG Raymond, P Ramchandani, A Shaunik, A Lendvay, D Sokal, ... Contraception 83 (3), 263-267, 2011 | 2 | 2011 |
A prospective, open-label, single-arm study to evaluate efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel A Lendvay, D Taylor, V Halpern, L Bahamondes, P Fine, S Ginde, ... Contraception 86 (3), 313, 2012 | 1 | 2012 |
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulation V Halpern, A Wheeless, V Brache, A Lendvay, L Cochón, D Taylor, ... Contraception: X 5, 100100, 2023 | | 2023 |
Continuous compared with cyclic use of oral contraceptive pills in the Dominican Republic: a randomized controlled trial. KN Kavita Nanda, A Lendvay, C Kwok, E Tolley, K Dubé, V Brache | | 2014 |
RCT of continuous versus cyclic use of combined oral contraceptive pills K Nanda, A Lendvay, C Kwok, E Tolley, K Dubé, V Brache Contraception 86 (3), 313, 2012 | | 2012 |
Jadelle and Implanon V Halpern, L Dorflinger, D Taylor, A Lendvay The European Journal of Contraception and Reproductive Health Care, 41, 0 | | |